Notice
This is not the latest version of this item. The latest version can be found at:https://dspace.mit.edu/handle/1721.1/139822.3
Fluorescence Sheds Light on DNA Damage, DNA Repair, and Mutations
| dc.contributor.author | Owiti, Norah A | |
| dc.contributor.author | Nagel, Zachary D | |
| dc.contributor.author | Engelward, Bevin P | |
| dc.date.accessioned | 2022-02-01T15:19:07Z | |
| dc.date.available | 2022-02-01T15:19:07Z | |
| dc.date.issued | 2021 | |
| dc.identifier.uri | https://hdl.handle.net/1721.1/139822 | |
| dc.description.abstract | © 2020 Elsevier Inc. DNA damage can lead to carcinogenic mutations and toxicity that promotes diseases. Therefore, having rapid assays to quantify DNA damage, DNA repair, mutations, and cytotoxicity is broadly relevant to health. For example, DNA damage assays can be used to screen chemicals for genotoxicity, and knowledge about DNA repair capacity has applications in precision prevention and in personalized medicine. Furthermore, knowledge of mutation frequency has predictive power for downstream cancer, and assays for cytotoxicity can predict deleterious health effects. Tests for all of these purposes have been rendered faster and more effective via adoption of fluorescent readouts. Here, we provide an overview of established and emerging cell-based assays that exploit fluorescence for studies of DNA damage and its consequences. | en_US |
| dc.language.iso | en | |
| dc.publisher | Elsevier BV | en_US |
| dc.relation.isversionof | 10.1016/J.TRECAN.2020.10.006 | en_US |
| dc.rights | Creative Commons Attribution-NonCommercial-NoDerivs License | en_US |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | en_US |
| dc.source | PMC | en_US |
| dc.title | Fluorescence Sheds Light on DNA Damage, DNA Repair, and Mutations | en_US |
| dc.type | Article | en_US |
| dc.identifier.citation | Owiti, Norah A, Nagel, Zachary D and Engelward, Bevin P. 2021. "Fluorescence Sheds Light on DNA Damage, DNA Repair, and Mutations." Trends in Cancer, 7 (3). | |
| dc.relation.journal | Trends in Cancer | en_US |
| dc.eprint.version | Author's final manuscript | en_US |
| dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
| eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
| dc.date.updated | 2022-02-01T15:13:39Z | |
| dspace.orderedauthors | Owiti, NA; Nagel, ZD; Engelward, BP | en_US |
| dspace.date.submission | 2022-02-01T15:13:40Z | |
| mit.journal.volume | 7 | en_US |
| mit.journal.issue | 3 | en_US |
| mit.license | PUBLISHER_CC | |
| mit.metadata.status | Authority Work and Publication Information Needed | en_US |
